SLC39A11-SDK2 Fusion FISH Probe
The SLC39A11-SDK2 Fusion FISH Probe is used to confirm a fusion of the SLC39A11 and SDK2 genes. The fusion of the SLC39A11 and SDK2 genes has been associated with Breast Invasive Carcinoma, and Pancreatic Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC39A11-SDK2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC39A11-SDK2-20-AQAQ | 20 (40 μL) | 200 μL |
|
SDK2 Gene Summary
The protein encoded by this gene is a member of the immunoglobulin superfamily. The protein contains two immunoglobulin domains and thirteen fibronectin type III domains. Fibronectin type III domains are present in both extracellular and intracellular proteins and tandem repeats are known to contain binding sites for DNA, heparin and the cell surface. This protein, and a homologous mouse sequence, are very similar to the Drosophila sidekick gene product but the specific function of this superfamily member is not yet known. Evidence for alternative splicing at this gene locus has been observed but the full-length nature of additional variants has not yet been determined. [provided by RefSeq, Jul 2008]
Gene Name: Sidekick Cell Adhesion Molecule 2
Chromosome: CHR17: 71330522 -71640227
Locus: 17q25.1
SLC39A11 Gene Summary
The Solute Carrier Family 39 Member 11 (SLC39A11) gene is located on chr17 :70642084-71088853 at 17q24.3-q25.1.
Gene Name: Solute Carrier Family 39 Member 11
Chromosome: CHR17: 70642084 -71088853
Locus: 17q24.3-q25.1
Gene Diseases
The SLC39A11 SDK2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Pancreatic Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|